Bi-allelic DNAH8 Variants Lead to Multiple Morphological Abnormalities of the Sperm Flagella and Primary Male Infertility.


Journal

American journal of human genetics
ISSN: 1537-6605
Titre abrégé: Am J Hum Genet
Pays: United States
ID NLM: 0370475

Informations de publication

Date de publication:
06 08 2020
Historique:
received: 19 03 2020
accepted: 05 06 2020
pubmed: 4 7 2020
medline: 21 10 2020
entrez: 4 7 2020
Statut: ppublish

Résumé

Sperm malformation is a direct factor for male infertility. Multiple morphological abnormalities of the flagella (MMAF), a severe form of asthenoteratozoospermia, are characterized by immotile spermatozoa with malformed and/or absent flagella in the ejaculate. Previous studies indicated genetic heterogeneity in MMAF. To further define genetic factors underlying MMAF, we performed whole-exome sequencing in a cohort of 90 Chinese MMAF-affected men. Two cases (2.2%) were identified as carrying bi-allelic missense DNAH8 variants, variants which were either absent or rare in the control human population and were predicted to be deleterious by multiple bioinformatic tools. Re-analysis of exome data from a second cohort of 167 MMAF-affected men from France, Iran, and North Africa permitted the identification of an additional male carrying a DNAH8 homozygous frameshift variant. DNAH8 encodes a dynein axonemal heavy-chain component that is expressed preferentially in the testis. Hematoxylin-eosin staining and electron microscopy analyses of the spermatozoa from men harboring bi-allelic DNAH8 variants showed a highly aberrant morphology and ultrastructure of the sperm flagella. Immunofluorescence assays performed on the spermatozoa from men harboring bi-allelic DNAH8 variants revealed the absent or markedly reduced staining of DNAH8 and its associated protein DNAH17. Dnah8-knockout male mice also presented typical MMAF phenotypes and sterility. Interestingly, intracytoplasmic sperm injections using the spermatozoa from Dnah8-knockout male mice resulted in good pregnancy outcomes. Collectively, our experimental observations from humans and mice demonstrate that DNAH8 is essential for sperm flagellar formation and that bi-allelic deleterious DNAH8 variants lead to male infertility with MMAF.

Identifiants

pubmed: 32619401
pii: S0002-9297(20)30192-0
doi: 10.1016/j.ajhg.2020.06.004
pmc: PMC7413861
pii:
doi:

Substances chimiques

Dnah8 protein, mouse 0
Axonemal Dyneins EC 3.6.4.2

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

330-341

Subventions

Organisme : NICHD NIH HHS
ID : P01 HD087157
Pays : United States
Organisme : NICHD NIH HHS
ID : R01 HD088412
Pays : United States

Informations de copyright

Copyright © 2020 American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Références

Annu Rev Physiol. 2007;69:423-50
pubmed: 17059358
Mol Biol Cell. 1998 Sep;9(9):2337-47
pubmed: 9725897
Am J Hum Genet. 2019 Apr 4;104(4):738-748
pubmed: 30929735
Sci Rep. 2019 Apr 30;9(1):6683
pubmed: 31040315
J Cell Biol. 2010 May 31;189(5):783-94
pubmed: 20513765
Mol Biol Cell. 2013 Dec;24(23):3689-96
pubmed: 24088566
Mol Cell Proteomics. 2013 Feb;12(2):330-42
pubmed: 23161514
J Exp Med. 2020 Feb 3;217(2):
pubmed: 31658987
Nat Rev Mol Cell Biol. 2017 Sep;18(9):533-547
pubmed: 28698599
Asian J Androl. 2020 Nov-Dec;22(6):608-615
pubmed: 32167074
Gene. 2017 Oct 30;633:48-53
pubmed: 28866084
Am J Hum Genet. 2018 Apr 5;102(4):636-648
pubmed: 29606301
Am J Hum Genet. 2019 Feb 7;104(2):331-340
pubmed: 30686508
Am J Respir Crit Care Med. 2005 Jun 15;171(12):1343-9
pubmed: 15750039
Hum Reprod Update. 2010 May-Jun;16(3):231-45
pubmed: 19934213
Am J Hum Genet. 2019 Dec 5;105(6):1148-1167
pubmed: 31735292
Hum Reprod. 2005 Oct;20(10):2790-4
pubmed: 15980003
J Proteomics. 2013 Feb 21;79:114-22
pubmed: 23268119
Cytoskeleton (Hoboken). 2015 Jan;72(1):16-28
pubmed: 25558044
Hum Reprod. 2016 Jan;31(1):10-23
pubmed: 26472152
J Med Genet. 2006 Jan;43(1):62-73
pubmed: 15937072
Am J Hum Genet. 2019 Jul 3;105(1):198-212
pubmed: 31178125
Hum Mol Genet. 2003 Apr 1;12 Spec No 1:R27-35
pubmed: 12668594
Am J Hum Genet. 2018 Dec 6;103(6):984-994
pubmed: 30471717
Cold Spring Harb Perspect Biol. 2016 Nov 1;8(11):
pubmed: 27527589
Am J Respir Cell Mol Biol. 2016 Aug;55(2):213-24
pubmed: 26909801
Am J Hum Genet. 2001 Apr;68(4):1030-5
pubmed: 11231901
Am J Hum Genet. 2019 Dec 5;105(6):1168-1181
pubmed: 31735294
Am J Hum Genet. 2018 Dec 6;103(6):995-1008
pubmed: 30471718
Am J Hum Genet. 2017 Jun 1;100(6):854-864
pubmed: 28552195
Dev Biol. 2005 Sep 1;285(1):57-69
pubmed: 16054618
Cold Spring Harb Perspect Biol. 2017 Jan 3;9(1):
pubmed: 27601632
Nat Commun. 2018 Feb 15;9(1):686
pubmed: 29449551
J Cell Biol. 2012 Jun 25;197(7):857-67
pubmed: 22733998
Biochim Biophys Acta. 2013 Jun-Jul;1829(6-7):487-90
pubmed: 23583720
Fertil Steril. 2014 Apr;101(4):945-9
pubmed: 24524830
Am J Hum Genet. 2018 Sep 6;103(3):413-420
pubmed: 30122541
Am J Hum Genet. 2008 Nov;83(5):547-58
pubmed: 18950741
Hum Reprod. 2016 Jun;31(6):1164-72
pubmed: 27094479
Cold Spring Harb Perspect Biol. 2017 Aug 1;9(8):
pubmed: 28765157
Asian J Androl. 2012 Jan;14(1):14-23
pubmed: 22198630
Hum Genet. 2020 Jan 16;:
pubmed: 31950240
Am J Hum Genet. 2014 Jan 2;94(1):95-104
pubmed: 24360805
Am J Hum Genet. 2018 Sep 6;103(3):400-412
pubmed: 30122540
J Diet Suppl. 2019;16(2):245-256
pubmed: 29451828
Hum Reprod. 2019 Oct 2;34(10):2071-2079
pubmed: 31621862
Mol Biol Cell. 2015 Oct 15;26(20):3596-605
pubmed: 26310446

Auteurs

Chunyu Liu (C)

Obstetrics and Gynecology Hospital, NHC Key Laboratory of Reproduction Regulation (Shanghai Institute of Planned Parenthood Research), State Key Laboratory of Genetic Engineering at School of Life Sciences, Fudan University, Shanghai 200011, China; Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Shanghai 200011, China; State Key Laboratory of Reproductive Medicine, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211116, China.

Haruhiko Miyata (H)

Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan.

Yang Gao (Y)

Reproductive Medicine Center, Department of Obstetrics and Gynecology, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, China; NHC Key Laboratory of Study on Abnormal Gametes and Reproductive Tract, Anhui Medical University, Hefei 230032, China; Key Laboratory of Population Health Across Life Cycle, Anhui Medical University, Ministry of Education of the People's Republic of China, Hefei 230032, China.

Yanwei Sha (Y)

Department of Andrology, United Diagnostic and Research Center for Clinical Genetics, School of Public Health & Women and Children's Hospital, Xiamen University, Xiamen 361005, Fujian, China; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics & Center for Molecular Imaging and Translational Medicine, School of Public Health, Xiamen University, Xiamen 361102, China.

Shuyan Tang (S)

Obstetrics and Gynecology Hospital, NHC Key Laboratory of Reproduction Regulation (Shanghai Institute of Planned Parenthood Research), State Key Laboratory of Genetic Engineering at School of Life Sciences, Fudan University, Shanghai 200011, China; Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Shanghai 200011, China.

Zoulan Xu (Z)

Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan; Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan.

Marjorie Whitfield (M)

INSERM U1016, Institut Cochin, Paris 75014, France; Centre National de la Recherche Scientifique UMR8104, Paris 75014, France; Faculté de Médecine, Université de Paris, Paris 75014, France.

Catherine Patrat (C)

INSERM U1016, Institut Cochin, Paris 75014, France; Centre National de la Recherche Scientifique UMR8104, Paris 75014, France; Faculté de Médecine, Université de Paris, Paris 75014, France; Laboratoire d'Histologie Embryologie-Biologie de la Reproduction-CECOS Groupe Hospitalier Universitaire Paris Centre, Assistance Publique-Hôpitaux de Paris, Paris 75014, France.

Huan Wu (H)

Reproductive Medicine Center, Department of Obstetrics and Gynecology, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, China; NHC Key Laboratory of Study on Abnormal Gametes and Reproductive Tract, Anhui Medical University, Hefei 230032, China; Key Laboratory of Population Health Across Life Cycle, Anhui Medical University, Ministry of Education of the People's Republic of China, Hefei 230032, China.

Emmanuel Dulioust (E)

INSERM U1016, Institut Cochin, Paris 75014, France; Centre National de la Recherche Scientifique UMR8104, Paris 75014, France; Faculté de Médecine, Université de Paris, Paris 75014, France; Laboratoire d'Histologie Embryologie-Biologie de la Reproduction-CECOS Groupe Hospitalier Universitaire Paris Centre, Assistance Publique-Hôpitaux de Paris, Paris 75014, France.

Shixiong Tian (S)

Obstetrics and Gynecology Hospital, NHC Key Laboratory of Reproduction Regulation (Shanghai Institute of Planned Parenthood Research), State Key Laboratory of Genetic Engineering at School of Life Sciences, Fudan University, Shanghai 200011, China; Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Shanghai 200011, China.

Keisuke Shimada (K)

Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan.

Jiangshan Cong (J)

Obstetrics and Gynecology Hospital, NHC Key Laboratory of Reproduction Regulation (Shanghai Institute of Planned Parenthood Research), State Key Laboratory of Genetic Engineering at School of Life Sciences, Fudan University, Shanghai 200011, China; Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Shanghai 200011, China.

Taichi Noda (T)

Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan.

Hang Li (H)

Reproductive Medicine Center, Department of Obstetrics and Gynecology, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, China; NHC Key Laboratory of Study on Abnormal Gametes and Reproductive Tract, Anhui Medical University, Hefei 230032, China; Key Laboratory of Population Health Across Life Cycle, Anhui Medical University, Ministry of Education of the People's Republic of China, Hefei 230032, China.

Akane Morohoshi (A)

Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan; Graduate School of Medicine, Osaka University, Osaka 565-0871, Japan.

Caroline Cazin (C)

Team Genetics Epigenetics and Therapies of Infertility, Institute for Advanced Biosciences, Grenoble Alpes University (UGA), INSERM U1209, Centre National de la Recherche Scientifique UMR 5309, Grenoble 38000, France; UM de genetique de l'infertilite et de diagnostic pre-implantatoire (GI-DPI), Centre Hospitalier Universitaire Grenoble Alpes (CHUGA), Grenoble 38000, France; Service de Génétique, Laboratoire Eurofins Biomnis, Lyon, France.

Zine-Eddine Kherraf (ZE)

Team Genetics Epigenetics and Therapies of Infertility, Institute for Advanced Biosciences, Grenoble Alpes University (UGA), INSERM U1209, Centre National de la Recherche Scientifique UMR 5309, Grenoble 38000, France; UM de genetique de l'infertilite et de diagnostic pre-implantatoire (GI-DPI), Centre Hospitalier Universitaire Grenoble Alpes (CHUGA), Grenoble 38000, France.

Christophe Arnoult (C)

Team Genetics Epigenetics and Therapies of Infertility, Institute for Advanced Biosciences, Grenoble Alpes University (UGA), INSERM U1209, Centre National de la Recherche Scientifique UMR 5309, Grenoble 38000, France.

Li Jin (L)

Obstetrics and Gynecology Hospital, NHC Key Laboratory of Reproduction Regulation (Shanghai Institute of Planned Parenthood Research), State Key Laboratory of Genetic Engineering at School of Life Sciences, Fudan University, Shanghai 200011, China.

Xiaojin He (X)

Reproductive Medicine Center, Department of Obstetrics and Gynecology, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, China; NHC Key Laboratory of Study on Abnormal Gametes and Reproductive Tract, Anhui Medical University, Hefei 230032, China; Key Laboratory of Population Health Across Life Cycle, Anhui Medical University, Ministry of Education of the People's Republic of China, Hefei 230032, China.

Pierre F Ray (PF)

Team Genetics Epigenetics and Therapies of Infertility, Institute for Advanced Biosciences, Grenoble Alpes University (UGA), INSERM U1209, Centre National de la Recherche Scientifique UMR 5309, Grenoble 38000, France; UM de genetique de l'infertilite et de diagnostic pre-implantatoire (GI-DPI), Centre Hospitalier Universitaire Grenoble Alpes (CHUGA), Grenoble 38000, France.

Yunxia Cao (Y)

Reproductive Medicine Center, Department of Obstetrics and Gynecology, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, China; NHC Key Laboratory of Study on Abnormal Gametes and Reproductive Tract, Anhui Medical University, Hefei 230032, China; Key Laboratory of Population Health Across Life Cycle, Anhui Medical University, Ministry of Education of the People's Republic of China, Hefei 230032, China.

Aminata Touré (A)

INSERM U1016, Institut Cochin, Paris 75014, France; Centre National de la Recherche Scientifique UMR8104, Paris 75014, France; Faculté de Médecine, Université de Paris, Paris 75014, France.

Feng Zhang (F)

Obstetrics and Gynecology Hospital, NHC Key Laboratory of Reproduction Regulation (Shanghai Institute of Planned Parenthood Research), State Key Laboratory of Genetic Engineering at School of Life Sciences, Fudan University, Shanghai 200011, China; Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Shanghai 200011, China; State Key Laboratory of Reproductive Medicine, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211116, China. Electronic address: zhangfeng@fudan.edu.cn.

Masahito Ikawa (M)

Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan; Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan; Graduate School of Medicine, Osaka University, Osaka 565-0871, Japan; Institute of Medical Science, University of Tokyo, Tokyo 108-8639, Japan. Electronic address: ikawa@biken.osaka-u.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH